Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Blood-brain Barrier00:49

The Blood-brain Barrier

Overview

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

MicroCT imaging of fibre water uptake in sugar maple (Acer saccharum) in response to freezing.

Micron (Oxford, England : 1993)·2025
Same author

Molecular Tumor Board of the University Medical Center Groningen (UMCG-MTB): outcome of patients with rare or complex mutational profiles receiving MTB-advised targeted therapy.

ESMO open·2024
Same author

Functionalized monodisperse microbubble production: microfluidic method for fast, controlled, and automated removal of excess coating material.

Microsystems & nanoengineering·2024
Same author

Embedded macrophages induce intravascular coagulation in 3D blood vessel-on-chip.

Biomedical microdevices·2023
Same author

<i>In situ</i> spatiotemporal characterization and analysis of chemical reactions using an ATR-integrated microfluidic reactor.

Lab on a chip·2023
Same author

Modular operation of microfluidic chips for highly parallelized cell culture and liquid dosing via a fluidic circuit board.

Microsystems & nanoengineering·2021

Related Experiment Video

Updated: May 18, 2026

Use of the MicroSiM (&#181;SiM) Barrier Tissue Platform for Modeling the Blood-Brain Barrier
09:10

Use of the MicroSiM (µSiM) Barrier Tissue Platform for Modeling the Blood-Brain Barrier

Published on: January 12, 2024

BBB on chip: microfluidic platform to mechanically and biochemically modulate blood-brain barrier function.

L M Griep1, F Wolbers, B de Wagenaar

  • 1BIOS, Lab on a Chip group, MESA+ Institute for Nanotechnology, University of Twente, PO Box 217, 7500 AE, Enschede, The Netherlands. l.m.griep@utwente.nl

Biomedical Microdevices
|September 8, 2012
PubMed
Summary

Researchers developed the smallest blood-brain barrier (BBB) model using microfluidics. This innovative model accurately mimics BBB function and dysfunction, offering new insights into neurodegenerative diseases.

More Related Videos

Generation of a Human iPSC-Based Blood-Brain Barrier Chip
10:20

Generation of a Human iPSC-Based Blood-Brain Barrier Chip

Published on: March 2, 2020

A Human Blood-Brain Interface Model to Study Barrier Crossings by Pathogens or Medicines and Their Interactions with the Brain
07:52

A Human Blood-Brain Interface Model to Study Barrier Crossings by Pathogens or Medicines and Their Interactions with the Brain

Published on: April 9, 2019

Related Experiment Videos

Last Updated: May 18, 2026

Use of the MicroSiM (&#181;SiM) Barrier Tissue Platform for Modeling the Blood-Brain Barrier
09:10

Use of the MicroSiM (µSiM) Barrier Tissue Platform for Modeling the Blood-Brain Barrier

Published on: January 12, 2024

Generation of a Human iPSC-Based Blood-Brain Barrier Chip
10:20

Generation of a Human iPSC-Based Blood-Brain Barrier Chip

Published on: March 2, 2020

A Human Blood-Brain Interface Model to Study Barrier Crossings by Pathogens or Medicines and Their Interactions with the Brain
07:52

A Human Blood-Brain Interface Model to Study Barrier Crossings by Pathogens or Medicines and Their Interactions with the Brain

Published on: April 9, 2019

Area of Science:

  • Neuroscience
  • Biomedical Engineering
  • Cell Biology

Background:

  • The blood-brain barrier (BBB) protects the brain but its dysfunction is implicated in neurodegenerative diseases.
  • Understanding BBB breakdown mechanisms is crucial for developing effective treatments.
  • Existing models often lack the complexity to fully replicate in vivo BBB conditions.

Purpose of the Study:

  • To develop a novel, miniaturized, and realistic in vitro model of the human blood-brain barrier.
  • To investigate the mechanical and biochemical modulation of BBB function.
  • To provide a platform for studying drug passage and neurodegenerative disease mechanisms.

Main Methods:

  • Utilized a microfluidic chip with the immortalized human brain endothelial cell line hCMEC/D3.
  • Integrated electrodes for measuring transendothelial electrical resistance (TEER) to assess barrier tightness.
  • Applied fluid shear stress and tumor necrosis factor alpha (TNF-α) stimulation to modulate barrier function.

Main Results:

  • hCMEC/D3 cells cultured on-chip maintained barrier integrity for up to 7 days, showing comparable TEER values to Transwell assays.
  • Shear stress significantly enhanced barrier tightness, increasing TEER by threefold.
  • TNF-α stimulation disrupted the barrier, decreasing TEER tenfold.
  • Expression of the tight junction protein Zonula Occludens-1 (ZO-1) was confirmed.

Conclusions:

  • The developed microfluidic BBB model is a realistic and sensitive platform for studying barrier function.
  • This model allows for detailed investigation of BBB dynamics under mechanical and inflammatory stimuli.
  • It holds potential for evaluating drug efficacy and advancing neurodegenerative disease research.